ACTIVE HALF-LIFE
2 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
2.5 - 5 mg/day
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Nakon Medical
WAREHOUSE
International Warehouse 3
SUBSTANCE
Letrozole
Discover Femara, an innovative anti-estrogen solution crafted by Nakon Medical. This powerful medication is renowned for its effectiveness in both medical and athletic environments. In the healthcare field, it is primarily utilized for treating estrogen-dependent cancers, such as breast cancer in women. Athletes and bodybuilders value it for its ability to counteract unwanted estrogen-related side effects, including water retention and gynecomastia in men.
As a non-steroidal aromatase inhibitor, Femara features Letrozole as its active ingredient. It is approved for human use, boasts a non-steroidal structure, and is free from androgenic properties. Additionally, it has a low toxicity profile, poses no risk to liver health, and contains no narcotic or addictive substances.
Effects of Femara
Upon administration, Femara effectively inhibits the aromatase enzyme responsible for estrogen production. By targeting the cytochrome P450 enzyme within aromatase, it can reduce estrogen activity by an impressive 75-95% from baseline levels over time.
Femara is classified as a third-generation aromatase inhibitor. While it shares similarities with Anastrozole, it is distinct in its action. In contrast, Clomid and Nolvadex work as estrogen receptor blockers, differing in their mechanisms and effects as they do not directly influence estrogen production.
Notably, Femara is generally regarded as safe for human use when taken as directed, with minimal side effects. However, misuse or underlying health conditions may elevate the risk of complications affecting various systems, including digestive (nausea, dry mouth), central nervous system (dizziness, depression), respiratory (shortness of breath, cough), and musculoskeletal (joint pain, osteoporosis). In the event of an overdose, symptomatic treatment is recommended.
Dosage, Cycle, and Reviews of Femara
Femara is administered orally and can be taken with or without food. It is rapidly and completely absorbed by the gastrointestinal tract, achieving a remarkable 99% bioavailability, unaffected by dietary intake.
The suggested dosage ranges from 0.25 to 5 mg daily, customized to individual requirements and tolerance. It can be employed through one of two approaches: 1) preventative use to avert complications from estrogenic steroids or 2) incorporated into steroid cycles to manage estrogen-related issues once symptoms manifest. In either case, Femara proves effective in preventing estrogen-related side effects, including water retention, increased body fat, and gynecomastia in men.
Before starting Femara, assessing potential risks is essential. Consulting with a healthcare professional is advised to identify and eliminate contraindications, such as pregnancy, breastfeeding, certain endocrine conditions in women, and known substance intolerances in both genders and in children.
Individuals with conditions like glucose-galactose malabsorption, lactase deficiency, or lactase intolerance should exercise caution to avoid adverse effects. Generally, dosage adjustments are unnecessary.
Keep out of reach of children. Intended for adult use only.
Warnings: